MEDICOX (Korea) Performance
| 054180 Stock | KRW 312.00 17.00 5.76% |
The company secures a Beta (Market Risk) of -0.29, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning MEDICOX are expected to decrease at a much lower rate. During the bear market, MEDICOX is likely to outperform the market. At this point, MEDICOX has a negative expected return of -0.41%. Please make sure to verify MEDICOX's standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to decide if MEDICOX performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days MEDICOX Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -24 B |
MEDICOX |
MEDICOX Relative Risk vs. Return Landscape
If you would invest 43,600 in MEDICOX Co on September 13, 2024 and sell it today you would lose (12,400) from holding MEDICOX Co or give up 28.44% of portfolio value over 90 days. MEDICOX Co is generating negative expected returns and assumes 5.9484% volatility on return distribution over the 90 days horizon. Simply put, 52% of stocks are less volatile than MEDICOX, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
MEDICOX Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MEDICOX's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MEDICOX Co, and traders can use it to determine the average amount a MEDICOX's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0693
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 054180 |
Estimated Market Risk
| 5.95 actual daily | 52 52% of assets are less volatile |
Expected Return
| -0.41 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MEDICOX is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MEDICOX by adding MEDICOX to a well-diversified portfolio.
MEDICOX Fundamentals Growth
MEDICOX Stock prices reflect investors' perceptions of the future prospects and financial health of MEDICOX, and MEDICOX fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MEDICOX Stock performance.
| Return On Equity | -48.98 | |||
| Return On Asset | -0.0413 | |||
| Profit Margin | (1.03) % | |||
| Operating Margin | (0.65) % | |||
| Current Valuation | 145.48 B | |||
| Shares Outstanding | 26.97 M | |||
| Price To Earning | 14.71 X | |||
| Price To Sales | 18.52 X | |||
| Revenue | 17.45 B | |||
| EBITDA | (8.04 B) | |||
| Cash And Equivalents | 4.19 B | |||
| Cash Per Share | 5.51 X | |||
| Total Debt | 325.47 M | |||
| Debt To Equity | 1.53 % | |||
| Book Value Per Share | 498.16 X | |||
| Cash Flow From Operations | (7.24 B) | |||
| Total Asset | 102.48 B | |||
| Retained Earnings | (95.44 B) | |||
| Current Asset | 4.7 B | |||
| Current Liabilities | 10.51 B | |||
About MEDICOX Performance
By analyzing MEDICOX's fundamental ratios, stakeholders can gain valuable insights into MEDICOX's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MEDICOX has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MEDICOX has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
ChoongAng Ocean Co., Ltd. engages in shipbuilding, display, alternative energy, and other businesses.Things to note about MEDICOX performance evaluation
Checking the ongoing alerts about MEDICOX for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MEDICOX help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MEDICOX generated a negative expected return over the last 90 days | |
| MEDICOX has high historical volatility and very poor performance | |
| MEDICOX Co has accumulated 325.47 M in total debt with debt to equity ratio (D/E) of 1.53, which is about average as compared to similar companies. MEDICOX has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist MEDICOX until it has trouble settling it off, either with new capital or with free cash flow. So, MEDICOX's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MEDICOX sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MEDICOX to invest in growth at high rates of return. When we think about MEDICOX's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 17.45 B. Net Loss for the year was (23.94 B) with profit before overhead, payroll, taxes, and interest of 2.1 B. | |
| MEDICOX Co has accumulated about 4.19 B in cash with (7.24 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.51. |
- Analyzing MEDICOX's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MEDICOX's stock is overvalued or undervalued compared to its peers.
- Examining MEDICOX's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MEDICOX's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MEDICOX's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MEDICOX's stock. These opinions can provide insight into MEDICOX's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MEDICOX Stock analysis
When running MEDICOX's price analysis, check to measure MEDICOX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDICOX is operating at the current time. Most of MEDICOX's value examination focuses on studying past and present price action to predict the probability of MEDICOX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDICOX's price. Additionally, you may evaluate how the addition of MEDICOX to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |